is glp-1 a hoax Genetics: How Genes Affect Appetite, Semaglutide, and Tirzepatide Response Research shows GLP-1 drugs are

Its unclear whether 2025 will be an outlier or a trend, but federal employees and annuitants should prepare to pay more going forward and anticipate large premium increases in the future

GLP-1 agonists, such as semaglutide (Wegovy) and tirzepatide (Mounjaro), work by mimicking natural hormones that regulate appetite, blood sugar, and digestion

Potential mechanisms by which high or increased iodine intake raises autoimmune thyroid disease risk The increase in circulating antibodies associated with iodine fortification is probably due to a number of factors including the strong immunogenicity of highly iodinated Tg which may trigger an immune reaction against the thyroid gland ( Reference Zimmermann and Boelaert 25 , Reference Burek and Talor 26 )

A major observational study published in mid-2025 found that diabetic patients taking GLP-1 drugs faced a two- to threefold higher risk of developing nAMD compared to non-users